GRANTS

96 RESULTS

To submit a grant posting, please fill out our web form or download the form so that you can email us at grants@alzforum.org. List the sponsor name, amount, due date, and contact information. This is a free service.

Please Note: We remove grant postings after 6 months. If you would like your listing to be posted longer or taken down sooner, please contact us at grants@alzforum.org.

Biobehavioral and Technological Interventions to Attenuate Cognitive Decline in Individuals with Cognitive Impairment or Dementia (R15)

Sponsor: National Institutes of Health (NIH), National Institute of Nursing Research (NINR), National Institute on Aging (NIA)

Award: Academic Research Enhancement Award

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard due date for this FOA is February 25, 2015. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Standard AIDS dates apply, by 5 p.m. local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Biobehavioral and Technological Interventions to Attenuate Cognitive Decline in Individuals with Cognitive Impairment or Dementia (R01)

Sponsor: National Institutes of Health (NIH), National Institute of Nursing Research (NINR), National Institute on Aging (NIA)

Award: Research Project Grant

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Standard AIDS dates apply, by 5 p.m. local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Biobehavioral and Technological Interventions to Attenuate Cognitive Decline in Individuals with Cognitive Impairment or Dementia (R21)

Sponsor: National Institutes of Health, National Institute of Nursing Research, National Institute on Aging

Award: Exploratory/Developmental Grant

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Standard AIDS dates apply, by 5 p.m. local time of applicant organization. All types of types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

The Midlife in the United States Study (U19)

Sponsor: National Institutes of Health (NIH), National Institute on Aging (NIA)

Award: The purpose of this FOA is to solicit an application for the next five-year cycle of the Midlife in the United States (MIDUS) Study, a National Longitudinal Study of Health and Well-being. The goals of this next phase are to complete the third wave of longitudinal data collection and enhance content in the area of daily stress; complete the second wave of data collection of clinical biomarkers and affective neuroscience assessments; continue innovative sub-studies such as how psychosocial influences affect gene expression and novel methods to track and reinstate non-responders; connect these content areas through innovative analyses to data on health, functioning, personality, cognitive status, affective functioning, economic well-being, social relationships, and well-being; and maintain and enhance data distribution and user support. A central goal of the MIDUS study is to support data dissemination, user support of public use files, and encourage data use broadly by the scientific community.

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the dates specified on the website. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Global Brain and Nervous System Disorders Research Across the Lifespan (R01)

Sponsor: John E. Fogarty International Center; National Eye Institute; National Institute on Aging; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute on Drug Abuse; National Institute on Deafness and Other Communication Disorders; National Institute of Environmental Health Sciences; National Institute of Mental Health; National Institute of Neurological Disorders and Stroke; Office of Dietary Supplements.

Award: Research Project Grant

Due Date: Application Due Date(s): January 5, 2015; January 5, 2016; January 5, 2017. AIDS Application Due Date(s): January 5, 2015; January 5, 2016; January 5, 2017.

Global Brain and Nervous System Disorders Research Across the Lifespan (R21) (PAR-14-331)

Sponsor: John E. Fogarty International Center; National Institute on Aging; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute on Drug Abuse; National Institute on Deafness and Other Communication Disorders; National Institute of Environmental Health Sciences; National Institute of Mental Health; National Institute of Neurological Disorders and Stroke; Office of Dietary Supplements.

Award: Exploratory/Developmental Research Grant

Due Date: Application Due Dates: January 5, 2015; January 5, 2016; January 5, 2017. AIDS Application Due Dates: January 5, 2015; January 5, 2016; January 5, 2017.

Testing Interventions for Health-Enhancing Physical Activity (R01)

Sponsor: Office of Disease Prevention, National Cancer Institute, National Institute on Aging, National Institute on Alcohol Abuse and Alcoholism, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Office of Behavioral and Social Science Research, Office of Research on Women's Health

Due Date: New applications: October 31, 2014; June 5, 2015; February 5, 2015; October 5, 2016; June 5, 2017. Resubmission applications: November 5, 2014; July 5, 2015; March 5, 2015; November 5, 2016; July 5, 2017. AIDS Application Due Dates: January 7, 2015, September 7, 2015, May 7, 2016, January 7, 2015, September 7, 2017

Developing Interventions for Health-Enhancing Physical Activity (R21/R33)

Sponsor: Office of Disease Prevention, National Center for Complementary and Alternative Medicine, National Cancer Institute, National Institute on Aging, National Institute on Alcohol Abuse and Alcoholism, Office of Behavioral and Social Science Research, Office of Research on Women's Health

Due Date: For new applications: November 4, 2014; June 16, 2015; February 16, 2016; October 16, 2016; June 16, 2017 For resubmission applications: November 16, 2014; July 16, 2015; March 16, 2016; November 16, 2016; July 16, 2017

NINDS CREATE Devices: Translational and Clinical Studies on the Path to 510(k) (UH2/UH3)

Sponsor: National Institute of Neurological Disorders and Stroke

Due Date: October 21, 2014; February 11, 2015, August 11, 2015, February 11, 2016, August 11, 2016, February 8, 2017, by 5 p.m. local time of applicant organization. AIDS Application Due Dates: January 7, 2015; May 7, 2015; September 7, 2015; May 7, 2016; September 7, 2016; and May 7, 2017, by 5 p.m. local time of applicant organization.

Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (UH2/UH3)

Sponsor: National Institute of Neurological Disorders and Stroke, NIH Blueprint for Neuroscience Research, National Center for Complementary and Alternative Medicine, National Institute on Aging, National Institute on Alcohol Abuse and Alcoholism, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institute on Drug Abuse, National Institute of Dental and Craniofacial Research, National Institute of Mental Health

Due Date: Application Due Date(s): October 21, 2014, February 11, 2015, August 11, 2015, February 11, 2016, August 11, 2016, February 8, 2017. AIDS Application Due Date(s): January 7, 2015, May 7, 2015, September 7, 2015, May 7, 2016, September 7, 2016, and May 7, 2017

Current Filters

No filters selected

Filter By